BMS-599626

• Description:

  An orally bioavailable pan-HER tyrosine kinase inhibitor with potential antineoplastic activity. BMS-599626 inhibits human epidermal growth factor receptors (HER) HER1, HER2 and HER4, thereby inhibiting the proliferation of tumor cells that overexpress these receptors.

• Shipping Conditions:

  RT

• Storage Conditions:

  -20°C

• Shelf Life:

  24months